Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels

Voltage-gated sodium (Na ᵥ) channels play a fundamental role in the generation and propagation of electrical impulses in excitable cells. Here we describe two unique structurally related nanomolar potent small molecule Na ᵥ channel inhibitors that exhibit up to 1,000-fold selectivity for human Na ᵥ1...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 110; no. 29; pp. E2724 - E2732
Main Authors McCormack, Ken, Santos, Sonia, Chapman, Mark L, Krafte, Douglas S, Marron, Brian E, West, Christopher W, Krambis, Michael J, Antonio, Brett M, Zellmer, Shannon G, Printzenhoff, David, Padilla, Karen M, Lin, Zhixin, Wagoner, P Kay, Swain, Nigel A, Stupple, Paul A, de Groot, Marcel, Butt, Richard P, Castle, Neil A
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 16.07.2013
National Acad Sciences
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Voltage-gated sodium (Na ᵥ) channels play a fundamental role in the generation and propagation of electrical impulses in excitable cells. Here we describe two unique structurally related nanomolar potent small molecule Na ᵥ channel inhibitors that exhibit up to 1,000-fold selectivity for human Na ᵥ1.3/Na ᵥ1.1 (ICA-121431, IC ₅₀, 19 nM) or Na ᵥ1.7 (PF-04856264, IC ₅₀, 28 nM) vs. other TTX-sensitive or resistant (i.e., Na ᵥ1.5) sodium channels. Using both chimeras and single point mutations, we demonstrate that this unique class of sodium channel inhibitor interacts with the S1–S4 voltage sensor segment of homologous Domain 4. Amino acid residues in the “extracellular” facing regions of the S2 and S3 transmembrane segments of Na ᵥ1.3 and Na ᵥ1.7 seem to be major determinants of Na ᵥ subtype selectivity and to confer differences in species sensitivity to these inhibitors. The unique interaction region on the Domain 4 voltage sensor segment is distinct from the structural domains forming the channel pore, as well as previously characterized interaction sites for other small molecule inhibitors, including local anesthetics and TTX. However, this interaction region does include at least one amino acid residue [E1559 (Na ᵥ1.3)/D1586 (Na ᵥ1.7)] that is important for Site 3 α-scorpion and anemone polypeptide toxin modulators of Na ᵥ channel inactivation. The present study provides a potential framework for identifying subtype selective small molecule sodium channel inhibitors targeting interaction sites away from the pore region.
Bibliography:http://dx.doi.org/10.1073/pnas.1220844110
2Present address: P. Kay Wagoner Discovery and Development Consulting, Chapel Hill, NC 27516.
3Present address: Walter and Eliza Hall Institute of Medical Research Biotechnology Centre, Bundoora, VIC 3086, Australia.
1Present address: Arisan Therapeutics, Inc., San Diego, CA 92121.
Edited by Kurt G. Beam, University of Colorado at Denver, Aurora, CO, and approved June 5, 2013 (received for review December 10, 2012)
Author contributions: K.M., M.L.C., and N.A.C. designed research; K.M., S.S., M.L.C., M.J.K., B.M.A., S.G.Z., D.P., and Z.L. performed research; K.M., S.S., B.E.M., C.W.W., K.M.P., Z.L., P.K.W., N.A.S., P.A.S., M.d.G., and R.P.B. contributed new reagents/analytic tools; K.M., S.S., M.L.C., M.J.K., B.M.A., S.G.Z., D.P., Z.L., and N.A.C. analyzed data; and K.M., D.S.K., and N.A.C. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1220844110